TF and leukemia: NUP98-HOXA9 is an IDR-containing TF chimera, and IDR-driven LLPS promotes chromatin occupancy of the chimeric TF, enhancing oncogene expression in a “super enhancers (SEs)” mode and inducing leukemia transformation (18, 90).